Search research articles
Contact Us
Filters
Showing results (151-160 of 212) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2013
Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi
Umberto Vitolo, Marco Ladetto, Carola Boccomini, et al.
Blood Advances
|
June 29, 2022
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
Valentina Tabanelli, Federica Melle, Giovanna Motta, et al.
American Journal of Hematology
|
October 5, 2016
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
Nicola Polverelli, Massimo Breccia, Giulia Benevolo, et al.
Blood
|
July 22, 2021
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project
Ranjana H Advani, Tetiana Skrypets, Monica Civallero, et al.
Thrombosis and Haemostasis
|
April 28, 2017
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)
Roberto Mario Santi, Manuela Ceccarelli, Elisa Bernocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2017
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
Umberto Vitolo, Marek Trněný, David Belada, et al.
British Journal of Haematology
|
November 28, 2008
Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial
Barry W Hancock, Wendi Qian, David Linch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma
Franck Morschhauser, John Radford, Achiel Van Hoof, et al.
Bone Marrow Transplantation
|
July 8, 2021
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
Sergio Cortelazzo, Michael Mian, Andrea Evangelista, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study
Maurizio Martelli, Luca Ceriani, Emanuele Zucca, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 212) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2013
Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi
Umberto Vitolo, Marco Ladetto, Carola Boccomini, et al.
Blood Advances
|
June 29, 2022
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
Valentina Tabanelli, Federica Melle, Giovanna Motta, et al.
American Journal of Hematology
|
October 5, 2016
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
Nicola Polverelli, Massimo Breccia, Giulia Benevolo, et al.
Blood
|
July 22, 2021
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project
Ranjana H Advani, Tetiana Skrypets, Monica Civallero, et al.
Thrombosis and Haemostasis
|
April 28, 2017
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)
Roberto Mario Santi, Manuela Ceccarelli, Elisa Bernocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2017
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
Umberto Vitolo, Marek Trněný, David Belada, et al.
British Journal of Haematology
|
November 28, 2008
Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial
Barry W Hancock, Wendi Qian, David Linch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma
Franck Morschhauser, John Radford, Achiel Van Hoof, et al.
Bone Marrow Transplantation
|
July 8, 2021
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
Sergio Cortelazzo, Michael Mian, Andrea Evangelista, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study
Maurizio Martelli, Luca Ceriani, Emanuele Zucca, et al.
Page
of 22